Q3 above estimates: Reported sales grew 5%; we estimate 10% comparable sales growth after adjusting for GST. EBTIDA grew 33% (EBITDA margin improved 330 bps to 16.5%) supported by change in mix towards higher ASP products. PAT growth moderated to 15% due to lower other income.